Larvol Delta - Biodexa-Provides-Update-on-Progression-Free-and-Overall-Survival-in-Phase-1-Study-of-MTX110-in-Recurrent-Glioblastoma

panobinostat (MTX110) - Biodexa Pharma

https://www.globenewswire.com/news-release/2024/10/04/2958311/0/en/Biodexa-Provides-Update-on-Progression-Free-and-Overall-Survival-in-Phase-1-Study-of-MTX110-in-Recurrent-Glioblastoma.html

Oct 4, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next